Tag
epidiolex
- US Senate bill would finally allow CBD in food and drinks
- Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B
- GW Pharma shares soar 21% on rising revenues
- FDA's new draft guidelines could speed up CBD drug approvals
- Ottawa's strict CBD rules block $2.5B market potential: report
- Company e‑learning platform to help UK doctors get up to speed on weed
- 'CBD Nation' doc aims to treat stigma with medical success stories
- US deschedules first cannabis-based medicine Epidiolex
- U.K. reduces wait times for patients accessing cannabis-based medicines
- GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder
- GW Pharmaceuticals' Cannabis-Based Epilepsy Drug Gets EU Approval
- GW Pharma Doubles Sales on Strong Uptake of CBD Drug Epidiolex